Cart summary

You have no items in your shopping cart.

Ki20227

SKU: orb1302959

Description

Ki-20227 is a potent and selective small molecule inhibitor of the c-Fms/CSF1R tyrosine kinase with an IC50 of 2 nM. It also exhibits activity against VEGFR2 and c-Kit/PDGFRβ. This inhibitor is a valuable research tool for studying tumor-associated macrophages, angiogenesis, and related oncogenic pathways in both cellular and animal models.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

Key Properties

CAS Number623142-96-1
MW480.54
Purity99.88% (May vary between batches)
FormulaC24H24N4O5S
SMILESCOc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1
TargetCSF-1R,VEGFR,c-Fms,c-Kit,PDGFR
SolubilityDMSO:55 mg/mL (114.45 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.16 mM)

Bioactivity

Target IC50
VEGFR2:12 nM|CSF1R:2 nM
In Vivo
Ki20227 reduces the number of tartrate-resistant acid phosphatase-positive osteoclast-like cells on bone surfaces in ovariectomized (ovx) rats. Furthermore, in the Ki20227-treated mice, the number of CD11b(+), Gr-1(+), and Ly-6 g(+) cells in the spleen were decreased and the CII-induced cytokine production in splenocytes isolated from the Ki20227-treated arthritic mice was also reduced. In EAE animal model, Ki20227 inhibits the turn-over/expansion of myeloid cells provoked by the immunization and subsequent MOG-specific T cell responses.
In Vitro
Ki20227 hasn't inhibition for other kinases tested, such as EGFR, Fms-like tyrosine kinase-3, or c-Src (c-src proto-oncogene product). Ki20227 also inhibits the M-CSF-dependent growth of M-NFS-60 cells but not the M-CSF-independent growth of A375 human melanoma cells in vitro. Ki20227 has an inhibition against M-CSF-dependent reactions, such as lipopolysaccharide-induced TNF-α production, which was enhanced by M-CSF in vitro.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

CSF-1 receptor, CSF1R, CSF-1R, CD117, c-Fms, cFms, colony stimulating factor 1 receptor, cKit, c-Kit, Inhibitor, Platelet-derived growth factor receptor, Ki 20227, Ki-20227, Ki20227, inhibit, SCFR, PDGFR, Vascular endothelial growth factor receptor, VEGFR, VEGFR2

Similar Products

  • Ki20227 [orb1224427]

    >98% (HPLC)

    623142-96-1

    480.5362

    C24H24N4O5S

    1 g, 25 mg, 500 mg, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Ki20227 (orb1302959)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 80.00
1 ml x 10 mM (in DMSO)
$ 140.00
5 mg
$ 140.00
10 mg
$ 200.00
25 mg
$ 340.00
50 mg
$ 530.00
100 mg
$ 820.00
200 mg
$ 1,100.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry